| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 764HZ2554D |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-13 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Eosinophilic Esophagitis | 2 | D057765 | ClinicalTrials |
| Rhinitis, Allergic, Seasonal | 2 | D006255 | ClinicalTrials |
| Scleroderma, Systemic | 2 | D012595 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 2 | D054990 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Keloid | 2 | D007627 | ClinicalTrials |
| Pulmonary Fibrosis | 2 | D011658 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109465 |
| FDA SRS | 764HZ2554D |
CONTENTS